SCHEMBL4854701

SCHEMBL4854701

[CH2]CCC(=O)OCCOCCOC

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.39
TSHR P16473 5/20 0.38
ALDH1A1 P00352 4/20 0.38
TP53 P04637 2/20 0.38
HIF1A Q16665 2/20 0.38
ADRA2A P08913 1/20 0.38
ADRA1A P35348 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPT P10636 1/20 0.36
BLM P54132 1/20 0.36
ABCB11 O95342 1/20 0.34
CYP3A4 P08684 1/20 0.34
ADRA2B P18089 1/20 0.34
OPRD1 P41143 1/20 0.34
SCN5A Q14524 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
THRB P10828 1/20 0.33
CA2 P00918 1/20 0.32
EPHX2 P34913 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4847373 0.94 DGKA (0.43) DGKATSHRALDH1A1ADRA2AADRA1A
SCHEMBL22510580 0.87 ADRA2A (0.48) DGKATSHRALDH1A1TP53HIF1A
SCHEMBL2302053 0.87 ADRA2A (0.48) DGKATSHRALDH1A1TP53HIF1A
SCHEMBL13268865 0.87 ADRA2A (0.48) DGKATSHRALDH1A1TP53HIF1A
SCHEMBL22662461 0.85 DGKA (0.43) DGKATSHRALDH1A1TP53HIF1A
SCHEMBL4849689 0.84 ALDH1A1 (0.52) DGKATSHRALDH1A1TP53HIF1A
SCHEMBL4856244 0.83 TSHR (0.40) DGKATSHRALDH1A1TP53HIF1A
SCHEMBL130621 0.83 DGKA (0.52) DGKATSHRALDH1A1TP53HIF1A
SCHEMBL9903608 0.83 DGKA (0.57) DGKATSHRALDH1A1ADRA2AADRA1A
SCHEMBL9903196 0.83 DGKA (0.57) DGKATSHRALDH1A1ADRA2AADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7329694-B2 Ocular lens JOHNSON & JOHNSON VISION CARE, INC. (US) 2008-02-12 US disclosed
EP-1445641-B1 OCULAR LENS JOHNSON & JOHNSON VISION CARE (US) 2007-10-03 EP disclosed
US-20040201820-A1 Ocular lens JOHNSON & JOHNSON VISION CARE, INC. 2004-10-14 US disclosed
US-20040198938-A1 Monomers, polymers and ophthalmic lenses JOHNSON & JOHNSON VISION CARE, INC. 2004-10-07 US disclosed
EP-1445641-A1 OCULAR LENS Johnson & Johnson Vision Care, Inc. (US) 2004-08-11 EP disclosed
EP-1424339-A1 MONOMERS, POLYMERS AND OPHTHALMIC LENSES Johson & Johnson Vision Care Inc. (US) 2004-06-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040198938-A1 Monomers, polymers and ophthalmic lenses LOXL1, CRYAA, UACA DGKA 1711/4885TSHR 4300/4885ALDH1A1 1939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.